Results 1 to 10 of about 406,651 (306)

Novel <i>RAD50</i> variants lead to Nijmegen Breakage Syndrome-like disorder and unplanned recombinant human growth hormone treatment response. [PDF]

Front Endocrinol (Lausanne)
BackgroundHuman RAD50 gene mutations cause Nijmegen Breakage Syndrome-like disease, characterized by severe prenatal and postpartum growth retardation and microcephaly.
Gong Y, Jiang M, Wu S, Guo S, Lyu Y.
europepmc   +2 more sources

Nutritional Counseling in Children with Growth Hormone Deficiency Treated with Recombinant Human Growth Hormone: Analysis of Growth Response Parameters. [PDF]

Biomedicines
Background and Objectives: Growth failure is the main symptom of growth hormone deficiency (GHD) in children. The standard treatment for GHD is the administration of recombinant human growth hormone (rhGH).
Budzulak J, Majewska KA, Kędzia A.
europepmc   +2 more sources

Human growth hormone.

The Turkish journal of pediatrics, 1966
Z Laron
openaire   +3 more sources

Déficit de hormona de crecimiento: influencia de la pubertad en la respuesta al tratamiento

Anales de Pediatría, 2022
Resumen: Introducción: La talla baja es motivo de consulta frecuente en Endocrinología Pediátrica, precisando en ocasiones tratamiento con hormona del crecimiento (GH).
María José Sánchez Malo, Juan Hidalgo Sanz, Cristina Hernández Tejedor, María García Ventura, Marta Ferrer Lozano, Jose Ignacio Labarta Aizpún, Antonio de Arriba Muñoz   +6 more
doaj   +1 more source

Vitamin D and Parathyroid Hormone during Growth Hormone Treatment

Children, 2022
Background. There is some controversy concerning a potential interaction between vitamin D and PTH and the GH/IGF-1 axis. The goal of this study is to assess vitamin D and PTH status in children with GH deficiency at diagnostic and during treatment with ...
Teodoro Durá-Travé, Fidel Gallinas-Victoriano   +1 more
doaj   +1 more source

Laron syndrome: An experience of treatment of two cases

Journal of Clinical and Translational Endocrinology Case Reports, 2021
Laron syndrome or growth hormone insensitivity is a rare disease presenting with severe postnatal growth failure. Clinically, in most circumstances, it is indistinguishable from growth hormone deficiency.
Hiya Boro, Sk Hammadur Rahman, Saurav Khatiwada, Sarah Alam, Rajesh Khadgawat   +4 more
doaj   +1 more source

Prader-Willi syndrome and growth hormone therapy: exploring the precise management of hypothalamic short stature: A review [PDF]

Precision and Future Medicine, 2023
Prader-Willi syndrome (PWS) is a rare genetic disorder characterized by various clinical features linked to hypothalamic/pituitary gland abnormalities. Growth hormone deficiency is a prominent feature of PWS that results in poor linear growth and delayed
Aram Yang
doaj   +1 more source

Effects of human growth hormone on gonadotropin-releasing hormone neurons in mice [PDF]

Korean Journal of Pediatrics, 2010
PurposeRecombinant human growth hormone (rhGH) has been widely used to treat short stature. However, there are some concerns that growth hormone treatment may induce skeletal maturation and early onset of puberty.
Janardhan P. Bhattarai, Shin Hye Kim, Seong Kyu Han, Mi Jung Park   +3 more
doaj   +1 more source

Investigating significant health trends in growth hormone treatments registry: rationale, aims and design of a nationwide prospective registry (study protocol)

Orphanet Journal of Rare Diseases, 2023
Background Somatropin treatment is indicated in a variety of disorders including growth hormone (GH) deficiency, Prader–Willi and Turner syndrome, chronic renal insufficiency and others. To date, almost all studies have been limited to single GH products,
Dirk Schnabel, Ilonka Kreitschmann-Andermahr, Christian J. Strasburger, David Pittrow, Christine Pausch, Joachim Woelfle, for the INSIGHTS-GHT Study Group   +6 more
doaj   +1 more source

Human Growth Hormone [PDF]

Diabetes, 1959
THE recent isolation of human growth hormone from pituitary glands collected at autopsy has been of major importance in the investigation of human pituitary physiology.1 , 2 Metabolic studies have confirmed the remarkable anabolic and growth-promoting actions of this hormone in man,3 , 4 in contrast to the negative or equivocal clinical results ...
openaire   +2 more sources